FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries

November 25, 2011 updated by: Assistance Publique - Hôpitaux de Paris

Prospective Study Randomized Multicentric On the Optimization Of the Installation Of Stent By Measurement Of the Intra-Coronary Pressure

Hypothesis : it is known that the stent must be well opened out in order to avoid restenosis into the stent. Intra coronary pressure would allow the stent to be well deployed and so the restenose into the stent should diminish.

Primary purpose : this study intend to test the hypothesis of optimal spreading of coronary stent guided with pressure into coronary arteritis comparing 2 strategies with patients having a coronary procedure with stent, excluded patients with myocardial infarction.

Study Overview

Status

Completed

Detailed Description

It is a randomized study, intending to treat, comparing the optimisation of the opening out of a stent into a coronar artery either guided with angiographic images only or with the assistance of pressure measurements plus angiographic control.

Several French centers participate to demonstrate superiority of one strategy. The criterion of principal judgement is the whole of cardiac events, criterion made up with the cardiac death, myocardial infarction, revascularisation by coronary bridging and/or angioplasty and positivity of the effort test.

Secondary criterions are :

  • comparing cost to efficacy of the two strategies
  • evaluating the angiographic restenosis into an under group of 200 patients (100 patients into each group)
  • determining the optimal threshold of measurement of intra coronary pressure in a multicentric population
  • comparing the ability of the different stents used to optimised the intra coronary pressure measurements

Study Type

Interventional

Enrollment (Actual)

800

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • European Georges Pompidou's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patient sent to coronal angioplasty with putting of an active stent to treat a restenosis

Exclusion Criteria:

  • acute myocardial infarction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
Intra coronary measures of pressure
Intra coronary measures of pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The first group of patients will have a coronary procedure with stent and his good deployment will be controlled with angiographic images
Time Frame: during de study
The first group of patients will have a coronary procedure with stent and his
during de study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
At 6 months cardiac events will be registered: patients will undergo a scintigraphic and effort test with thallium and a clinical exam
Time Frame: during the study
At 6 months cardiac events will be registered: patients will undergo a
during the study
At 12 and 18 months they will undergo a clinical exam and cardiac events will be registered
Time Frame: during the study
At 12 and 18 months they will undergo a clinical exam and cardiac events will be registered
during the study
Complementary examination
Time Frame: during the study
Complementary examination
during the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Antoine LAFONT, Pr,MD,PhD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2001

Primary Completion (Actual)

January 1, 2008

Study Completion (Actual)

January 1, 2008

Study Registration Dates

First Submitted

October 20, 2005

First Submitted That Met QC Criteria

October 20, 2005

First Posted (Estimate)

October 21, 2005

Study Record Updates

Last Update Posted (Estimate)

November 29, 2011

Last Update Submitted That Met QC Criteria

November 25, 2011

Last Verified

March 1, 2007

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe